Indiana Healthcare Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Indiana Healthcare Today.

Press releases published on June 11, 2026

Jun. 11, 2026

TOMI Environmental Solutions Highlights Massive Biosecurity Opportunity Ahead of FIFA World Cup

Indeterminate GlobeNewswire

Jun. 11, 2026

60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement with Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement

Indeterminate GlobeNewswire

Jun. 11, 2026

InspireMD Announces 30-Day Results from the CGUARDIANS II Clinical Trial of the CGuard Prime 80 cm Implant for Use in TCAR Procedures

Indeterminate GlobeNewswire

Jun. 11, 2026

FLYTE EXPANDS STRATEGIC RELATIONSHIP WITH VOLATO BY JOINING VAUNT PLATFORM

Indeterminate GlobeNewswire

Jun. 11, 2026

ORYZON Presents Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia (AML) at European Hematology Association (EHA) 2026 Annual Congress 

Indeterminate GlobeNewswire

Jun. 11, 2026

Bionano Announces Multiple Publications in 2026 Describing Unique Utility of OGM in Studies of Reproductive Health and Prenatal Genetic Disorders

Indeterminate GlobeNewswire

Jun. 11, 2026

Theriva™ Biologics Announces Results from VCN-01 Phase 1 Clinical Trial in Head and Neck Cancer Published in Clinical Cancer Research

Indeterminate GlobeNewswire

Jun. 11, 2026

Loma Linda University Health and Nudj Health Launch Integrated Whole-Person Primary Care Model Designed to Advance the Future of Healthcare Delivery

Indeterminate GlobeNewswire

Jun. 11, 2026

Tris Pharma to Present on Dual NOP/MOP Receptor Agonist in Pain Management and Substance Use Disorder at the College on Problems of Drug Dependence (CPDD) 88th Annual Scientific Meeting, 2026

Indeterminate GlobeNewswire

Jun. 11, 2026

Immuneering Announces First Patient Dosed in Pivotal Phase 3 MAPKeeper 301 Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer

Indeterminate GlobeNewswire

Jun. 11, 2026

Medicus Pharma Initiates Groundbreaking PRECISION-E2 Phase 2a Study of Teverelix® in Endometriosis utilizing the Emirati Genome Program

Indeterminate GlobeNewswire

Jun. 11, 2026

Spinach® is the Number One Vape Brand in Canada

Indeterminate GlobeNewswire

Jun. 11, 2026

AC Immune to Receive Research Grant from Goradia Family for Development of ACI-7104 in Parkinson’s Disease

Indeterminate GlobeNewswire

Jun. 11, 2026

Metabolic Health After 40: What Perimenopause and Menopause Mean for Weight Management

Indeterminate GlobeNewswire

Jun. 11, 2026

BlossomHill Therapeutics Presents Initial Clinical Data from Dose Escalation in Ongoing Phase 1/1b Trial of Novel Macrocyclic CLK Inhibitor, BH-30236, in Patients with R/R AML or HR-MDS at EHA 2026

Indeterminate GlobeNewswire

Jun. 11, 2026

Bereaved Mothers Give a Gift to Every Grieving Father: The “All Fathers Day” Free Grief Support Bundle. A Documentary Film. A Live Father’s Day Support Group. Free Online Courses. A Dedicated Community. All Free. All at AllFathersDay.com

Indeterminate GlobeNewswire

Jun. 11, 2026

C4 Therapeutics Presents Phase 1 Data at European Hematology Association (EHA) 2026 Congress Highlighting Cemsidomide as a Potential Best-in-Class IKZF1/3 Degrader for Multiple Myeloma in Heavily Pretreated Relapsed/Refractory Population

Indeterminate GlobeNewswire

Jun. 11, 2026

Medicenna Strengthens U.S. Patent Estate with Newly Issued and Allowed Patents Across its IL-2, IL-4 and IL-13 Superkine Platforms

Indeterminate GlobeNewswire

Jun. 11, 2026

Quetzal Therapeutics Announces First Patient Dosed in Phase 3 QUATRO-APL Trial of QTX-2101 for Frontline Acute Promyelocytic Leukemia

Indeterminate GlobeNewswire

Jun. 11, 2026

Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026

Indeterminate GlobeNewswire